Dr. Robert Pearl, a plastic surgeon and CEO of Kaiser Permanente Medical Group, wrote a misinformed, biased article on radiation oncology in Forbes and on KevinMD.Com. He points at radiation oncologist equipment ownership as a cost-driver but botches any clinical information accuracy in a folksy, readable way for the uninformed. In my opinion, it appears more like an easy way to share Kaiser as 'low cost' where it competes in non-CON states. I have written comments both on KevinMD and Forbes (not posted/approved yet) suggesting he share Kaiser's utilization data to show Kaiser is any better. What do you think? Is his portrayal of prostate SBRT as mainstream reasonable?